For most people, the most likely result is that the dose will simply be less effective
However, dose-dependent gastrointestinal effects limit efficacy, so drugs with GLP-1 and GCG pharmacology can also target alternative pathways and may expand the therapeutic index (132)
It means we do not have enough human data to confirm safety with the same confidence as injectable semaglutide
If youre in California, schedule a free consultation today and take that next step toward feeling your best
GLP-1 + GIP: A Powerful Combination Some newer medications, like tirzepatide, combine GLP-1 with another hormone called GIP (glucose-dependent insulinotropic polypeptide)
14 Consistency Evaluation Approvals Including Ceftazidime, Pioglitazone, and Metronidazolesignaling quality alignment with originators